Robuta

https://research.rug.nl/en/activities/temporary-committee-managing-patient-registries-for-expensive-dru/ Temporary Committee Managing patient registries for expensive drugs (ZINL) (External organisation)... patient registriesexpensive drugstemporarycommitteemanaging https://www.sciencedaily.com/releases/2015/12/151214185543.htm Expensive, exploratory research biopsies overused in early studies of new cancer drugs |... Early trials of new cancer drugs often require extra biopsies to determine the drugs' biochemical and physiological effects. A new study shows that this... exploratory research https://ducknetweb.blogspot.com/2008/08/kidney-patients-denied-expensive-life.html Kidney patients denied 'too expensive' life-extending drugs - UK - Medical Quack Money is the issue, so will the UK have the worst cancer survival figures in Europe? There still have to be some happy medium whereby drug... too expensivekidneypatientsdenied https://www.kqed.org/forum/2010101871106/why-prescription-drugs-are-so-expensive-in-the-u-s Why Prescription Drugs are so Expensive in the U.S. | KQED One in four Americans who take prescription drugs have a difficult time affording their medicine. That's according to a recent report by the Kaiser Family... prescription drugsso expensivein the https://www.prweb.com/releases/hepatitis_c_new_drugs_effective_yet_expensive_polydna_recommends_gene_eden_vir_a_clinically_proven_cost_effective_hcv_remedy/prweb11552025.htm Hepatitis C: New Drugs Effective Yet Expensive; polyDNA Recommends Gene-Eden-VIR, a Clinically... Rochester, NY (PRWEB) February 09, 2014 -- polyDNA has learned that two studies showed that patients who were given various combinations of antiviral pill... https://www.hks.harvard.edu/publications/are-drugs-substitutes-or-complements-intensive-and-expensive-medical-treatment Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment | Harvard... Little is known about the relationship between variation in drug and non-drug medical treatment and how areas may substitute one type of care for the other.... https://dbrs.morningstar.com/research/430889/new-weight-loss-drugs-expensive-for-insurers-to-cover-but-may-help-address-costs-of-obesity New Weight Loss Drugs Expensive For Insurers to Cover, But May Help Address Costs of Obesity |... DBRS Morningstar published a commentary discussing the impact of the rapid growth in the usage of GLP-1 drugs on insurers in North America and Europe. Key hi https://blog.uehiro.ox.ac.uk/2008/01/paying-for-better-health-should-patients-be-able-to-pay-for-expensive-cancer-drugs/ Paying for better health: Should patients be able to pay for expensive cancer drugs? | Practical... Jan 25, 2008 - The price of strong egalitarianism in health-care is high.